Lipid extraction for mass spectrometry lipidomics

MA Martina Arends
MW Melanie Weber
CP Cyrus Papan
MD Markus Damm
MS Michal A. Surma
CS Christopher Spiegel
MD Minou Djannatian
SL Shengrong Li
LC Lisa Connell
LJ Ludger Johannes
MS Martina Schifferer
CK Christian Klose
MS Mikael Simons
ask Ask a question
Favorite

Mass spectrometry-based lipid analysis was performed by Lipo-type GmbH (Dresden, Germany) as described (Surma et al., 2021). If not indicated otherwise, 500 μg of tissue were used per extraction. Lipids were extracted using a two-step chloroform/methanol procedure using homogenized tissues re-suspended in a water phase, extracted with chloroform/methanol 10:1 (V:V) and 2:1 (V:V) in the first and second step, respectively (Ejsing et al., 2009). Samples were spiked with internal lipid standard mixture containing: cardiolipin 16:1/15:0/15:0/15:0 (CL, 50 pmol per extraction), ceramide 18:1; 2/17:0 (Cer, 30 pmol), diacylglycerol 17:0/17:0 (DAG, 100 pmol), hexosylceramide 18:1; 2/12:0 (HexCer, 30 pmol), lyso-phosphatidate 17:0 (LPA, 30 pmol), lyso-phosphatidylcholine 12:0 (LPC, 50 pmol), lyso-phosphatidylethanolamine 17:1 (LPE, 30 pmol), lyso-phosphatidylglycerol 17:1 (LPG, 30 pmol), lyso-phosphatidylinositol 17:1 (LPI, 20 pmol), lyso-phosphatidylserine 17:1 (LPS, 30 pmol), phosphatidate 17:0/17:0 (PA, 50 pmol), phosphatidylcholine 17:0/17:0 (PC, 150 pmol), phosphatidylethanolamine 17:0/17:0 (PE, 75 pmol), phosphatidylglycerol 17:0/17:0 (PG, 50 pmol), phosphatidylinositol 16:0/16:0 (PI, 50 pmol), phosphatidylserine 17:0/17:0 (PS, 100 pmol), cholesterol ester 20:0 (CE, 100 pmol), sphingomyelin 18:1; 2/12:0; 0 (SM, 50 pmol), triacylglycerol 17:0/17:0/17:0 (TAG, 75 pmol), Gb3 18:1; 2/17:0; 0 (200 pmol), GM1-D3 18:1; 2/18:0; 0 (200 pmol), GM3-D3 18:1; 2/18:0; 0 (50 pmol), LacCer d18:1/12:0 (50 pmol), Sulfatide d18:1; 2/12:0; 0 (20 pmol) and cholesterol D6 (Chol, 300 pmol). After extraction, the organic phase was transferred to an infusion plate and dried in a speed vacuum concentrator. 1st step dry extract was re-suspended in 7.5 mM ammonium acetate in chloroform/methanol/propanol (1:2:4, V:V:V) and 2nd step dry extract in 33% ethanol solution of methylamine in chloroform/methanol (0.003:5:1; V:V:V). All liquid handling steps were performed using Hamilton Robotics STARlet robotic platform with the Anti Droplet Control feature for organic solvents pipetting.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A